Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TAK

Recent news which mentions TAK

< Previous 1 2 3 4 5 6 7 8 9 Next >
Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs
Tickers NEWS TAK
Tags Movers Market News Guidance
From Benzinga
Earnings Scheduled For May 8, 2025
Tickers AAOI ABCL ABEV ABL
Tags IGM JYNT GEOS
From Benzinga
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients
Tickers NEWS PFE TAK
Tags Health Care News Large Cap
From Benzinga
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
Tickers AAPG NEWS TAK
Tags Health Care Analyst Color Trading Ideas
From Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Tickers AMGN AZN BIIB BMY
Tags Biotech AZN Government
From Benzinga
Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer
Tickers NEWS PTGX TAK
Tags Market News Movers Briefs
From Benzinga
Earnings Scheduled For January 30, 2025
Tickers AAPL ABCB ABG AJG
Tags TSCO FLWS EMN
From Benzinga
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
Tickers NBIX NEWS TAK
Tags Market News NBIX Movers
From Benzinga
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
Tickers ABT COST FOOD GIS
Tags Health Care COST bans
From Benzinga
Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency
Tickers ASIA NEWS TAK
Tags Briefs Movers Markets
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Tickers MRK NEWS RHHBY SNY
Tags RHHBY Biotech Expert Ideas
From Benzinga
Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst
Tickers KROS NEWS TAK
Tags Benzinga Contracts Analyst Ratings
From Benzinga
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Tickers ACIU NEWS TAK
Tags Market News ACIU Movers
From Benzinga
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
Tickers F FAN ICLN NEWS
Tags climate change FAN News
From Benzinga
Preview: Takeda Pharmaceutical's Earnings
Tickers TAK
Tags Benzinga TAK Market News
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags Trading Ideas News Health Care
From Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
Tickers JNJ NEWS TAK
Tags Benzinga Top Stories TAK
From Benzinga
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Tickers JNJ NEWS PTGX TAK
Tags Analyst Ratings General TAK
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags Expert Ideas ELVN Biotech
From Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Tickers HKMPF HKMPY MCKPF MNKTQ
Tags FDA Stories That Matter Biotech
From Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Tickers ASND NEWS TAK
Tags Biotech FDA Stories That Matter
From Benzinga
Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
Tickers NEWS TAK
Tags Health Care Large Cap Trading Ideas
From Benzinga
TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q1 2024
Tickers TAK
Tags NYSE:TAK Earnings Reports TAK
From InvestorPlace
3 Biotech Stocks to Buy on the Dip: July 2024
Tickers JAZZ PCRX TAK
Tags TAK JAZZ Stocks to Buy
From InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Tickers ALMS BMY JNJ NEWS
Tags TAK General Analyst Ratings
From Benzinga
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Tickers LLY MORF NEWS TAK
Tags Briefs Market News Analyst Color
From Benzinga
Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report
Tickers BX LBO NEWS PSP
Tags PSP TAK Media
From Benzinga
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers BTDR LEN NEE NEWS
Tags Markets Movers Market News
From Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers AAN AGRI ALLG AMCX
Tags CETX TAK ATRA
From Benzinga
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
Tickers NEWS OVID TAK
Tags why it's moving General TAK
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.